Authors : Oyekemi Oyetoro

Volume/Issue : Volume 10 - 2025, Issue 10 - October

Google Scholar : https://tinyurl.com/mr32evz3

Scribd : https://tinyurl.com/ydmcu2uy

DOI : https://doi.org/10.38124/ijisrt/25oct1106

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Multiple Myeloma (MM) is a blood disorderliness or malignancy with significant clinical and heterogeneity making it difficult for making strong, reliable, and accurate prognosis. While the usual or conventional staging systems provide significant risk stratification, they are inadequate in the capturing of the complexities of Multiple Myeloma. Artificial Intelligence and Machine Learning tools and models have emerged as capable technologies for the analysis of high dimensional data to improve prognostic accuracy. The study utilized a systematic review approach to investigate the application of Artificial Intelligence and Machine Learning based technologies in the prediction of survival outcomes for Multiple Myeloma patients. PRISMA 2020 framework was adopted for the study. A systematic search of Google scholar for relevant studies was conducted between 2015 to July, 2025. Using relevant inclusion and exclusion criteria, and screening process, a total number of 10 research articles were considered to be very relevant to the study. The study result shows that artificial and machine based models such as Random Forest and Gradient Boosting algorithms demonstrate strong predictive power, with reported Area Under the Curve (AUC) and Concordance Index (C-index) values often ranging from 0.72 to 0.85. The models is capable of integrating different data types, including clinical parameters, laboratory results, high- dimensional genomics, and advanced imaging. The evidence suggests that AI/ML models can significantly enhance risk stratification, identify novel prognostic biomarkers, and offer more personalized survival predictions compared to conventional methods. Integrating AI into clinical practice holds the potential to optimize treatment strategies and improve outcomes for MM patients.

Keywords : Multiple Myeloma, Artificial Intelligence, Machine Learning, Survival Prediction, Prognosis, Systematic Review.

References :

1. Bao, L., Wang, Y., Zhuang, J., Liu, A., Dong, Y., Chu, B., Chen, X., Lu, M., Shi, L., Gao, S., Fang, L., Xiang, Q., & Ding, Y. (2022). Machine learning-based overall survival prediction of elderly patients with multiple myeloma from multicentre real-life data. Frontiers in Oncology, 12, 922039. https://doi.org/10.3389/fonc.2022.922039
2. Belmonte, J. M., Blanquer, M., Bernabé, G., Jiménez, F., & García, J. M. (2025). Survival risk prediction in hematopoietic stem cell transplantation for multiple myeloma. Journal of Integrative Bioinformatics, 20240053. https://doi.org/10.1515/jib-2024-0053
3. Cowan, A. J., Green, D. J., Kwok, M., Lee, S., Coffey, D. G., Holmberg, L. A., Tuazon, S., Gopal, A. K., & Libby, E. N. (2022). Diagnosis and management of multiple myeloma: A review. JAMA, 327(5), 464–477. https://doi.org/10.1001/jama.2022.0003
4. Garcia-Ortiz, A., Rodriguez-Garcia, Y., Encinas, J., Maroto-Martin, E., Castellano, E., Teixidó, J., & Martinez-Lopez, J. (2021). The role of tumor microenvironment in multiple myeloma development and progression. Cancers, 13(2), 217.
5. Gehlot, S., Gupta, A., & Gupta, R. (2021). A CNN-based unified framework utilizing projection loss in unison with label noise handling for multiple Myeloma cancer diagnosis. Medical Image Analysis, 72, 102099. https://doi.org/10.1016/j.media.2021.102099
6. Guerrero, C., Tamariz-Amador, A., Andreadis, C., et al. (2022). A machine learning model based on tumor and immune biomarkers to predict undetectable MRD and survival outcomes in multiple myeloma. Blood Cancer Discovery, 3(4), 328-343.
7. Maura, F., Rajanna, A. R., Ziccheddu, B., Poos, A. M., Derkach, A., Maclachlan, K., ... & Landgren, O. (2024). Genomic classification and individualized prognosis in multiple myeloma. Journal of Clinical Oncology, 42(16_suppl), 8002-8002.
8. Mosquera Orgueira, A., González Pérez, M. S., Diaz Arias, J., Rosiñol, L., Oriol, A., Teruel, A. I., ... & Mateos, M. V. (2022). Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group. Blood Cancer Journal, 12(1), 1-8. https://doi.org/10.1038/s41408-022-00652-z
9. Lawanson, M. O., Griffin, E., Berleant, D., Farmer, P., Hodge, R., Schinke, C., Ashby, C., & Bauer, M. A. (2025). How does age at diagnosis influence multiple myeloma survival? Empirical evidence. Healthcare, 13(2637). https://doi.org/10.3390/healthcare13202637
10. Padala, S. A., Barsouk, A., Barsouk, A., Rawla, P., Vakiti, A., Kolhe, R., & Ajebo, G. H. (2021). Epidemiology, staging, and management of multiple myeloma. Medical Sciences, 9(1), 3. https://doi.org/10.3390/medsci9010003
11. Ren, L., Xu, B., Xu, J., Li, J., Jiang, J., Ren, Y., & Liu, P. (2023). A machine learning model to predict survival and therapeutic responses in multiple myeloma. International Journal of Molecular Sciences, 24(7), 6683. https://doi.org/10.3390/ijms24076683
12. Sachpekidis, C., Enqvist, O., Ulén, J., Kopp-Schneider, A., Pan, L., Mais, E. K., ... & Dimitrakopoulou-Strauss, A. (2024). Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 51(7), 2293–2307. https://doi.org/10.1007/s00259-024-06668-z
13. Sakemura, R., Hefazi, M., Siegler, E. L., Cox, M. J., Larson, D. P., Hansen, M. J., ... & Kenderian, S. S. (2022). Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. Blood, The Journal of the American Society of Hematology, 139(26), 3708-3721.
14. Shah, U. A., & Mailankody, S. (2020). Emerging immunotherapies in multiple myeloma. BMJ, 370.
15. Shah, K. U., Millan, K. A., Pula, A. E., Kubicki, T. F., Cannova, J., Wu, S., ... & Drazer, M. W. (2025). RNAseq-Based Machine Learning Models for Prognostication of Multiple Myeloma. medRxiv. [Preprint]
16. Witte, M. L., Pleguezuelo, M. L., van der Velden, V. H., et al. (2023). Progression-free survival prediction of multiple myeloma patients in five European countries using machine learning models. Annals of Oncology, 34(S2), S550. https://doi.org/10.1016/j.annonc.2023.09.708
17. Zhong, H., Huang, D., Wu, J., Chen, X., Chen, Y., & Huang, C. (2023). 18F-FDG PET/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma. BMC Medical Imaging, 23(1), 87. https://doi.org/10.1186/s12880-023-01033-2
18. Zhou, Y. (2023). Integrating web data mining and machine learning algorithms to predict progression free survival and overall survival in multiple myeloma patients. [Master's thesis, Uppsala University].